Results 61 to 70 of about 2,169,751 (270)

Mitral valve remodeling in the development of obstructive hypertrophic cardiomyopathy

Indian Heart Journal, 2023
Approximately 2/3 of patients with hypertrophic cardiomyopathy (HCM) have significant left ventricular outflow tract obstruction (LVOTO), which is caused by the interaction mitral valve apparatus and the hypertrophied septum.
Francesco Moroni, Abhishek Chaturvedi, Ehsan Jafree, Zachary M. Gertz   +3 more
doaj   +1 more source

Expert Perspectives: Toward Treat‐to‐Target Management in Adult Idiopathic Inflammatory Myopathies

Arthritis &Rheumatology, EarlyView.
Treat‐to‐target has transformed the management of several rheumatic diseases through predefined therapeutic goals, structured disease assessment, and timely treatment adjustment. Despite major advances in the understanding and treatment of idiopathic inflammatory myopathies (IIM), a formal treat‐to‐target framework for adult IIM has not yet been ...
Shiri Keret, Nantakarn Pongtarakulpanit, Rohit Aggarwal   +2 more
wiley   +1 more source

Systolic anterior motion of mitral valve following resection of subaortic membrane and intracardiac repair of tetralogy of fallot

Annals of Cardiac Anaesthesia, 2020
Systolic anterior motion (SAM) of the mitral valve is commonly observed in patients with hypertrophic obstructive cardiomyopathy and in few patients after mitral valve repair or aortic valve replacement.
Krishna Prasad Gourav, Bhupesh Kumar, Imran Bhat, Anand K Mishra   +3 more
doaj   +1 more source

Adult Presentation of Subaortic Stenosis with Subaortic Membrane Treated with Surgical Removal

Journal of Cardiovascular Development and Disease, 2022
Subaortic stenosis (SAS) is a rare heart disease in adults with an unclear etiology and variable clinical presentation. In some cases, SAS appears as hypertrophic cardiomyopathy with obstruction due to the accompanying systolic anterior motion of the ...
Se Hun Kang, In Jai Kim, Won-Jang Kim
doaj   +1 more source

Exposure‐adjusted safety and efficacy of GLP‐I and GLP‐1/GIP receptor agonists compared with non‐GLP‐I for weight management and type 2 diabetes: Based on FDA medical and statistical reports of 34 280 safety and 36 312 efficacy subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to contextualize glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonists safety and efficacy regarding weight management (WM); we analysed Food and Drug Administration (FDA) Medical Reviews to analyse 14 medications using patient‐exposure year normalization and ...
Aishwarya Prasad, Anshu Arora, Arun Arora, Jeena Vaid, Arif Khan   +4 more
wiley   +1 more source

HIP ROTATION RANGE OF MOTION AND ITS IMPACT ON LOWER LIMB ALIGNMENT ON LANDING [PDF]

, 2010
The purpose of the present study was to compare lower limb alignment at initial ground contact between groups with normal and abnormal hip rotation range of motion.
Breen, S, Kenny, IC, Harrison, AJ
core   +5 more sources

Hypertension in obesity: A focus on individualized pharmacotherapy and the role of body composition, on behalf of the European Society of Hypertension Working Group on Diabetes and Metabolic Risk Factors and Working Group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence

British Journal of Clinical Pharmacology, EarlyView.
Hypertension in obesity represents a major global health challenge, closely linked to the global epidemics of obesity, type 2 diabetes and metabolic dysfunction. Excess adiposity contributes to elevated blood pressure through multiple, interrelated mechanisms, including activation of the renin–angiotensin–aldosterone system, sympathetic nervous system ...
Christina Antza, Andrej Belancic, Jens Jordan, Alberto Esteban, Anna Oliveras, Ryan McNally, Panagiota Anyfanti, Jorie Versmissen, María S. Fernández‐Alfonso, Vasilios Kotsis, Thomas Weber, Alexandre Persu, Reinhold Kreutz   +12 more
wiley   +1 more source

Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy

Journal of Veterinary Internal Medicine, 2020
Background N‐terminal pro B‐type natriuretic peptide (NT‐proBNP) and cardiac troponin‐I (cTnI) are biomarkers commonly evaluated in cats with suspected heart disease.
Joonbum Seo, Jessie Rosie Payne, Jose Novo Matos, Wesley Wynne Fong, David J. Connolly, Virginia Luis Fuentes   +5 more
doaj   +1 more source

Type II myocardial infarction and latent LVOT obstruction due to Systolic Anterior Motion of mitral valve

, 2019
Left ventricular outflow tract obstruction is a well-recognized feature in hypertrophic cardiomyopathy but can occur in other clinical scenarios when anatomically susceptible heart is subjected to permissive physiological conditions that provoke systolic
Makrides Constantinos*
core   +1 more source

Conservative approach to mitral valve replacement in hypertrophic cardiomyopathy with systolic anterior motion -a case report [PDF]

, 2020
Streszczenie W pracy przedstawiono przypadek 60-letniego pacjenta zakwalifikowanego do wykonania zabiegu chirurgicznego z rozpoznaną kardiomiopatią przerostową (hypertrophic cardiomyo pathy -HCM), znacznie podwyższonym gradientem w drodze odpływu z lewej
Krzysztof Szymoński, Grzegorz Wasilewski, Boguslaw Kapelak, Prof Krzysztof Bartuś, Bogdan Suder, Krzysztof Bartus, Jerzy Sadowski   +6 more
core